Aisling Capital as of Dec. 31, 2016
Portfolio Holdings for Aisling Capital
Aisling Capital holds 18 positions in its portfolio as reported in the December 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Loxo Oncology | 30.1 | $129M | 4.0M | 32.12 | |
| Zeltiq Aesthetics | 16.3 | $70M | 1.6M | 43.52 | |
| Aimmune Therapeutics | 14.2 | $61M | 3.0M | 20.45 | |
| Versartis | 8.7 | $38M | 2.5M | 14.90 | |
| Viewray (VRAYQ) | 5.4 | $23M | 7.5M | 3.13 | |
| Esperion Therapeutics (ESPR) | 4.8 | $21M | 1.6M | 12.52 | |
| Adma Biologics (ADMA) | 4.3 | $19M | 3.6M | 5.12 | |
| T2 Biosystems | 3.5 | $15M | 2.8M | 5.26 | |
| Transenterix | 2.5 | $11M | 8.3M | 1.30 | |
| Cidara Therapeutics Inc Common Stock Usd 0.0001 (CDTX) | 2.5 | $11M | 1.0M | 10.40 | |
| Agile Therapeutics | 2.4 | $10M | 1.8M | 5.70 | |
| Paratek Pharmaceuticals | 1.7 | $7.4M | 483k | 15.40 | |
| Syros Pharmaceuticals | 1.4 | $6.2M | 509k | 12.16 | |
| Cempra | 0.8 | $3.3M | 1.2M | 2.80 | |
| Intersect Ent | 0.6 | $2.7M | 225k | 12.10 | |
| Chimerix (CMRX) | 0.5 | $2.2M | 473k | 4.60 | |
| Pernix Therapeutics Hldgs In dbcv 4.250% 4/0 | 0.1 | $625k | 2.5M | 0.25 | |
| Pernix Therapeutics Holdings | 0.1 | $407k | 210k | 1.94 |
